Dr. David Mathai
Medical Director, Psychiatry & Psychedelic Research, Sattva Medicine
I am a board-certified psychiatrist with advanced pharmacology research training as a postdoctoral fellow with the Johns Hopkins Center for Psychedelic and Consciousness Research and am currently a Clinical Assistant Professor at Baylor College of Medicine. My other professional roles include contributing to the Baylor Center for Medical Ethics as a Health Policy Scholar with the Ethical and Legal Implications of Psychedelics in Society (ELIPSIS) Program and to the American Society of Ketamine Physicians, Psychotherapists, and Practitioners (ASKP3) as Expert Faculty. I completed medical school and residency training with Baylor College of Medicine, with a focus on medication management, psychotherapy, and research.
As a researcher, I have investigated and produced numerous scientific publications on topics such as behavioral models of addiction and cognitive impairment, the neuropsychiatric effects of cannabis, and the complex properties of psychedelic-type therapies like ketamine, MDMA, and psilocybin. I have worked as a scientific collaborator, study physician, and session therapist for multiple clinical trials of psilocybin-assisted interventions. I have also worked as a physician-investigator for Phase 1 – 3 schizophrenia and depression drug development studies in commercial settings.
As a clinician, I treat individuals struggling with a variety of conditions, including depression, anxiety, and trauma. My approach to mental health is broadly informed and focused most on helping people cultivate deeper relationships with themselves and others, so they can live in ways that feel resilient, vibrant, and true. I acknowledge the harm that has come from the over-medicalization of suffering and believe in only the judicious use of psychiatric medications. Decisions around prescribing or deprescribing are made collaboratively with patients and include careful exploration of the reasons for medication change, the best available evidence, and risk-benefit analysis. I am currently accepting patients for virtual psychiatry/psychotherapy appointments in Florida, Texas, and Maryland through my private practice, Sattva Medicine: https://sattvamedicine.com/